Literature DB >> 27530932

[Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels].

R M Hermann1, H Christiansen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27530932     DOI： 10.1007/s00066-016-1032-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  3 in total

Review 1.  Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer.

Authors:  Mack Roach
Journal:  Cancer       Date:  2014-03-03       Impact factor: 6.860

2.  Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.

Authors:  Pirus Ghadjar; Stefanie Hayoz; Jürg Bernhard; Daniel R Zwahlen; Tobias Hölscher; Philipp Gut; Matthias Guckenberger; Guido Hildebrandt; Arndt-Christian Müller; Ludwig Plasswilm; Alexandros Papachristofilou; Lukas Stalder; Christine Biaggi-Rudolf; Marcin Sumila; Helmut Kranzbühler; Yousef Najafi; Piet Ost; Ngwa C Azinwi; Christiane Reuter; Stephan Bodis; Khanfir Kaouthar; Peter Wust; George N Thalmann; Daniel M Aebersold
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

3.  No supra-additive effects of goserelin and radiotherapy on clonogenic survival of prostate carcinoma cells in vitro.

Authors:  Robert M Hermann; Dag Schwarten; Stefanie Fister; Carsten Grundker; Margret Rave-Frank; Mirko Nitsche; Andrea Hille; Paul Thelen; Heinz Schmidberger; Hans Christiansen
Journal:  Radiat Oncol       Date:  2007-08-26       Impact factor: 3.481
  3 in total
  2 in total

1.  Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.

Authors:  Lars Budäus; Jonas Schiffmann; Markus Graefen; Hartwig Huland; Pierre Tennstedt; Alessandra Siegmann; Dirk Böhmer; Volker Budach; Detlef Bartkowiak; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2017-05-03       Impact factor: 3.621

Review 2.  Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.

Authors:  Pirus Ghadjar; Daniel M Aebersold; Clemens Albrecht; Dirk Böhmer; Michael Flentje; Ute Ganswindt; Stefan Höcht; Tobias Hölscher; Felix Sedlmayer; Frederik Wenz; Daniel Zips; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2018-01-30       Impact factor: 3.621
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.